Pages that link to "Q42814654"

The following pages link to Tyrosine kinase receptor indistinguishable from the c-met protein (Q42814654):

Displaying 50 items.

• Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates (Q22010646) (← links)
• Cross-talk between the proto-oncogenes Met and Ron (Q22254408) (← links)
• Interplay between scatter factor receptors and B plexins controls invasive growth (Q24295561) (← links)
• A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor (Q24318269) (← links)
• HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death (Q24324832) (← links)
• Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy (Q24539692) (← links)
• Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity (Q24546366) (← links)
• Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor (Q24555664) (← links)
• The ltk gene encodes a novel receptor-type protein tyrosine kinase (Q24564727) (← links)
• Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor (Q24564783) (← links)
• RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP (Q24863529) (← links)
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib (Q24646295) (← links)
• A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype (Q24648317) (← links)
• The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells (Q27313466) (← links)
• Met receptor tyrosine kinase: enhanced signaling through adapter proteins (Q28140219) (← links)
• Functional regulation of semaphorin receptors by proprotein convertases (Q28203827) (← links)
• The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met (Q28207199) (← links)
• K252a inhibits the oncogenic properties of Met, the HGF receptor (Q28214703) (← links)
• The semaphorin 4D receptor controls invasive growth by coupling with Met (Q28219215) (← links)
• Induction of epithelial tubules by growth factor HGF depends on the STAT pathway (Q28259695) (← links)
• The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase (Q28280668) (← links)
• Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat (Q28571293) (← links)
• Hepatocyte growth factor (Q30048844) (← links)
• Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion (Q30445760) (← links)
• The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro (Q30450983) (← links)
• Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor). (Q33238614) (← links)
• Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing (Q33263389) (← links)
• Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. (Q33576236) (← links)
• Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models (Q33645135) (← links)
• Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression (Q33654173) (← links)
• High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo. (Q33727656) (← links)
• A point mutation in the MET oncogene abrogates metastasis without affecting transformation. (Q33731936) (← links)
• Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors (Q33769437) (← links)
• Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer (Q33779854) (← links)
• Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy (Q33828409) (← links)
• A novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells (Q33889099) (← links)
• Kinase inhibitors in cancer therapy: a look ahead (Q33897202) (← links)
• The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. (Q33922881) (← links)
• Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition. (Q33942266) (← links)
• Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway (Q33969327) (← links)
• The Met oncogene and basal-like breast cancer: another culprit to watch out for? (Q34173500) (← links)
• Discovery of a 5H-Benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer (Q34187026) (← links)
• Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis (Q34236194) (← links)
• Functional map and domain structure of MET, the product of the c- met protooncogene and receptor for hepatocyte growth factor/scatter factor (Q34267718) (← links)
• c-Met modulates RPE migratory response to laser-induced retinal injury (Q34342411) (← links)
• The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth (Q34386024) (← links)
• Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. (Q34419289) (← links)
• Invasive growth: from development to metastasis (Q34584035) (← links)
• Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis (Q34613189) (← links)
• Scatter-factor and semaphorin receptors: cell signalling for invasive growth (Q34632043) (← links)